Corteva, Inc. engages in the provision of seed and crop protection solutions. The company is headquartered in Indianapolis, Indiana and currently employs 21,500 full-time employees. The company went IPO on 2019-05-24. The firm is focused on progressing science-based innovations which deliver a range of agriculture products and services to customers. Its segments include Seed and Crop Protection. The Seed segment is engaged in developing and supplying commercial seed combining germplasm and traits that offer yield for farmers. The company offers seed and trait technologies that boost resilience to weather, pests, diseases, and herbicides used to manage weeds. Its brands include Pioneer seeds, Brevant seeds, Dairyland Seed, Hoegemeyer hybrids and Nutech seed. The Crop Protection segment serves the agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that support overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company offers herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides.
How did CTVA's recent EPS compare to expectations?
The most recent EPS for Corteva Inc is $1.5, beating expectations of $1.19.
How did Corteva Inc CTVA's revenue perform in the last quarter?
Corteva Inc revenue for the last quarter is $1.5
What is the revenue estimate for Corteva Inc?
According to 16 of Wall street analyst, the revenue estimate of Corteva Inc range from $7.15B to $6.43B
What's the earning quality score for Corteva Inc?
Corteva Inc has a earning quality score of B+/53.041. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Corteva Inc report earnings?
Corteva Inc next earnings report is expected in 2026-08-03
What are Corteva Inc's expected earnings?
Corteva Inc expected earnings is $4.73B, according to wall-street analysts.
Did Corteva Inc beat earnings expectations?
Corteva Inc recent earnings of $4.9B beat expectations.